Dr Anna Hudson, Senior Postdoctoral Fellow at NeuRA, has been awarded the Lung Foundation Australia/Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Research Fellowship. One in seven Australians over forty is affected by Chronic Obstructive Pulmonary Disease, a progressive disease which makes it hard to breathe and causes shortness of breath, progressing in its severity over time. People living with this disease usually experience coughing which produces large amounts of mucus, wheezing, shortness of breath, chest tightness, and other symptoms.
Commenting on her fellowship award Anna said, “my research work over the next two years will focus on looking at the way respiratory muscles are controlled in people with Chronic Obstructive Pulmonary Disease”.
“For most of us we rarely think about breathing – it is an automatic process, but for people with Chronic Obstructive Pulmonary Disease, they are often short of breath.”
“I am going to use my knowledge in the techniques to measure muscle and brain activity to detect impairments in the neural control of breathing in these people”, said Dr Hudson.
This is a disease which affects the quality of life and the everyday living of people affected by it. By looking at how the neural control of their breathing muscles is affected, Dr Hudson hopes to identify new targets, therapies and techniques to support and improve the lives of people living with Chronic Obstructive Pulmonary Disease.
More than 80,000 people are living with Parkinson’s disease in Australia, and of these, approximately two thirds will fall each year. Ensuing injuries, hospitalisations, fear of falling and caregiver burden are devastating, widespread and costly. As the prevalence of Parkinson’s disease will double between 2010 and 2040, the associated human and economic burden will also grow. Innovative therapies to improve […]